Biohaven CFO’s 175K Stock Options Signal Confidence & Future Share‑Price Growth
Biohaven CFO’s $0 option grant signals confidence in its neurologic‑immunology pipeline, aligning leadership incentives with long‑term value and digital‑health‑driven reimbursement strategies.
4 minutes to read